Dead B. Subtilis
Purine Metabolism Disorder
Jinling Hospital, ChinaEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Purine Metabolism Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
B. Subtilis Jinling Hospital, China | Early Phase 1 | C |
Same molecule, other indications
Dead B. Subtilis is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →